Latest News

TCT 23: Late-Breaking Clinical Trials Revealed
Written by: Radcliffe Cardiology
TCT 23: Late-Breaking Clinical Trials Revealed
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)
Written by: Merck
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin…
NOAH-AFNET 6 Trial: No Benefits of DOAC in Patients with Atrial High-Rate Episodes
Written by: Radcliffe Cardiology, Mirjam Boros
No Benefits of DOAC in Patients with Atrial High-Rate Episodes: The NOAH-AFNET 6 Trial
Written by: Radcliffe Cardiology
Radcliffe Cardiology partners with KDIGO for creation of independent medical education programmes
Switching to NOACs in Frail AF Patients: The FRAIL-AF Trial
Written by: Radcliffe Cardiology, Mirjam Boros
Switching to NOACs in Frail AF Patients: The FRAIL-AF Trial
Alvimedica launches the new Alvision™ KAPLAN curves radial portfolio for diagnostic procedures
Written by: Alvimedica
Alvimedica launches the new Alvision™ KAPLAN curves radial portfolio for diagnostic procedures
DELIVER Trial: Prespecified Analysis Demonstrates Dapagliflozin Benefits Across Subgroups
Written by: Radcliffe Cardiology, Jordan Rance
DELIVER Trial: Prespecified Analysis Demonstrates Dapagliflozin Benefits Across Subgroups
Latest AI technology improves echocardiogram reproducibility and repeatability
Written by: EchoNous
Latest AI technology improves echocardiogram reproducibility and repeatability
IC-OS Partnership
Written by: Radcliffe Cardiology
Radcliffe Cardiology partners with the International Cardio-Oncology Society for weekly educational…
Comparative Evaluation of Torsemide and Furosemide in Heart Failure: Impact on Patient-Reported Outcomes and Quality of Life - Findings from the TRANSFORM-HF Trial
Written by: Radcliffe Cardiology, Jordan Rance
Comparative Evaluation of Torsemide and Furosemide in Heart Failure: Impact on Patient-Reported Outcomes and…

External news

Written by: Cardiac Vascular News
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
Written by: Cardiac Vascular News
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
Written by: Medscape
First TAVR for Aortic Regurgitation Moves to Phase 3 Trial
Written by: Medscape
Thrombectomy Tops Thrombolysis in Pulmonary Embolism Trial
Written by: Cardiac Vascular News
Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results
Written by: Cardiac Vascular News
SmartCardia Receives FDA Clearance for Outpatient Cardiac Telemetry for Its 7-Lead ECG Patch and Cloud Platform
Written by: Medscape
SCD: Can Atrial Arrhythmias Predict Strokes?
Written by: heart.org - Heart news
Primary care professionals key to helping people achieve & maintain heart health
Written by: heart.org - Heart news
Early detection, intensive treatment critical for high-risk patients with Kawasaki Disease
Written by: heart.org - Heart news
La detección temprana y el tratamiento intensivo son cruciales para los pacientes de alto riesgo con enfermedad de Kawasaki